324 filings
Page 5 of 17
8-K
f0n6jw
9 Feb 21
Brooklyn ImmunoTherapeutics Announces Initiation of Phase 2 Trial of IRX-2 in Combination with Pembrolizumab and Chemotherapy in Triple Negative Breast Cancer
4:32pm
8-K
b9ojbde5dozpc5sd
4 Feb 21
NTN Buzztime Announces Date of Special Meeting of Stockholders
12:00am
8-K
a6dkja6m1
15 Jan 21
NTN Buzztime, Inc. Receives Noncompliance Notice from NYSE American
5:22pm
8-K
2sxvidyt6ghricnx80
23 Nov 20
Entry into a Material Definitive Agreement
7:02am
8-K
snhtyr31 drbkmzkp
13 Nov 20
NTN Buzztime, Inc. Reports Third Quarter 2020 Results
6:35am
8-K
d1ro4etxjxckzzc39lde
5 Nov 20
Changes in Registrant's Certifying Accountant
8:00am
8-K
qbe7jcegth9v
18 Sep 20
NTN Buzztime Enters Asset Purchase Agreement
5:19pm
8-K
bum my3ksyg3134aqwrb
14 Aug 20
Entry into a Material Definitive Agreement
5:16pm
8-K
liqyb8sv7j6g2
13 Aug 20
Enter into Definitive Merger Agreement
6:05am
8-K
vc1h65s uy6l6f6oe1k
12 Aug 20
NTN Buzztime, Inc. Receives Noncompliance Notice from NYSE American
4:55pm
8-K
tfen5ckcsu
7 Aug 20
NTN Buzztime, Inc. Reports Second Quarter 2020 Results
6:40am
8-K
kmhho
1 Jul 20
Termination of a Material Definitive Agreement
8:00am
8-K
0j81dwi8zw
17 Jun 20
Other Events
6:30am
8-K
z9yf w4eez
15 Jun 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
smuo7ogt5l zj41
2 Jun 20
Departure of Directors or Certain Officers
4:30pm
8-K
6717z8
19 May 20
NTN Buzztime, Inc. Reports First Quarter 2020 Results
4:10pm
8-K
yx3r szg3
21 Apr 20
Entry into a Material Definitive Agreement
4:15pm
8-K
ugf0sx 4pv
3 Apr 20
Departure of Directors or Certain Officers
4:10pm
8-K
rekf384
30 Mar 20
NTN Buzztime, Inc. Receives Noncompliance Notice from NYSE American
4:15pm
8-K
jqwqyvphvfxr1i
17 Mar 20
NTN Buzztime, Inc. Reports Fourth Quarter and Full Year 2019 Results
4:20pm